The company, a majority-owned affiliate of Ionis Pharmaceuticals, announced Sept. 23 the departures of CEO Paula Soteropoulos, President Sarah Boyce and COO Jeff Goldberg, effective immediately.
Danueb McDevitt, PhD, the chief business officer of Ionis was named interim CEO. The company didn’t announce interim replacements for the president or COO.
The leadership shakeup comes a year after the company launched its first FDA-approved drug, Tegsedi, a treatment for a rare disease called hereditary transthyretin amyloidosis, according to STAT.
More articles on pharmacy:
Carcinogen concerns prompt Sandoz to halt global distribution of heartburn drug
DEA raids some West Coast Kaiser Permanente pharmacies
California biotech files for bankruptcy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
